MARKET

DTIL

DTIL

Precision Biosciences
NASDAQ
4.700
+0.160
+3.52%
After Hours: 4.750 +0.05 +1.06% 19:32 03/28 EDT
OPEN
4.750
PREV CLOSE
4.540
HIGH
4.788
LOW
4.550
VOLUME
76.44K
TURNOVER
--
52 WEEK HIGH
15.97
52 WEEK LOW
3.610
MARKET CAP
37.09M
P/E (TTM)
4.514
1D
5D
1M
3M
1Y
5Y
1D
Director’s Bold Move: A Major Stock Purchase at Precision BioSciences
TipRanks · 1d ago
Precision Biosciences Price Target Maintained With a $60.00/Share by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
Benzinga · 1d ago
Precision BioSciences: Promising Advancements in Gene Editing and Strategic Growth Justify Buy Rating
TipRanks · 1d ago
Director’s Bold Move: A Strategic Investment in Precision BioSciences
TipRanks · 2d ago
Precision BioSciences Reports Positive 2024 Financial Results
TipRanks · 3d ago
Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 3d ago
PRECISION BIOSCIENCES, INC. FORM 10-K
Press release · 3d ago
More
About DTIL
More
Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Company's pipeline consists of in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision. ARCUS particularly generates defined outcomes due to predominant repair using homology directed repair (HDR) as opposed to non-homologous end joining (NHEJ). The Company’s in vivo gene editing programs include PBGENE-HBV, PBGENE-PMM, PBGENE-NVS, PBGENE-DMD, PBGENE-LL2, PBGENE-LL3 and iECURE-OTC. PBGENE-HBV program is designed for the potential treatment of chronic hepatitis B virus (HBV). The Company is pursuing development of PBGENE-PMM as a potential opportunity for treatment of m.3243 associated primary mitochondrial myopathy (PMM).
Recently
Symbol
Price
%Change

Webull offers Precision BioSciences Inc stock information, including NASDAQ: DTIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DTIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DTIL stock methods without spending real money on the virtual paper trading platform.